Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07191223

Evaluation of Knowledge on Tick-borne Encephalitis Virus (TBEV) Infection Among General Practitioners in France

Tick-borne encephalitis is a relatively rare disease (approximately 35 cases diagnosed per year), but most cases (86%) are due to contamination in France via a tick bite. Of the 71 cases reported over two years (May 2021 to May 2023), 94% of patients were hospitalized.

It is therefore important to consider and diagnose at the first signs to ensure appropriate follow-up and also to implement primary prevention in endemic/at-risk areas.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Service des maladies infectieuses et tropicales - CHU de Strasbourg - France

Strasbourg, 67091, France

Location status: Recruiting

Location contact

Aurélie VELAY, MD

SUB_INVESTIGATOR

Flore MULLER, MD

PRINCIPAL_INVESTIGATOR

Yves HANSMANN, MD, PhD

CONTACT

[email protected]

33 3 69 55 09 78

Yves HANSMANN, MD, PhD

PRINCIPAL_INVESTIGATOR

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Be a doctoral student or in training
  • Practice in France
  • Agree to participate in the survey.

Exclusion criteria

  • Refusal to participate in the study

Treatment and study plan

Primary outcomes

  1. Tick-borne meningoencephalitis knowledge score

    Time frame: Up to 2 years

Study contacts

Contact information is provided by the study sponsor or research team.

Yves HANSMANN, MD

CONTACT

[email protected]

33 3 69 55 09 78

Sponsors and collaborators

Lead sponsor

University Hospital, Strasbourg, France

Other

Registry information

Official study title

Evaluation of Knowledge on Tick-borne Encephalitis Virus (TBEV) Infection Among General Practitioners and Specialists in Endemic Areas and Outside Endemic Areas in France

Acronym: CoMTBEV

Important dates

Study start
2024
Primary completion
2026
Study completion
2026
First posted
Sep 24, 2025
Registry last updated
Sep 24, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.